UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 212

Sortiert nach

The increasing incidence of thyroid cancer: the influence of access to care

Thyroid (New York, N.Y.), 2013-07, Vol.23 (7), p.885

2013

Volltextzugriff (PDF)

STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy

Biomaterials, 2018-05, Vol.163 (C), p.67-75

2018

Volltextzugriff (PDF)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

Journal for immunotherapy of cancer, 2019-07, Vol.7 (1), p.184-184, Article 184

2019

Volltextzugriff (PDF)

Second Primary Cancers After an Index Head and Neck Cancer: Subsite-Specific Trends in the Era of Human Papillomavirus–Associated Oropharyngeal Cancer

Journal of clinical oncology, 2011-02, Vol.29 (6), p.739-746

2011

Volltextzugriff (PDF)

Molecular Pathways: Inflammation-Associated Nitric-Oxide Production as a Cancer-Supporting Redox Mechanism and a Potential Therapeutic Target

Clinical cancer research, 2013-10, Vol.19 (20), p.5557-5563

2013

Volltextzugriff (PDF)

Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization

Nature communications, 2015-03, Vol.6 (1), p.6676-6676, Article 6676

2015

Volltextzugriff (PDF)

Predictors of Survival in Mucosal Melanoma of the Head and Neck

Annals of surgical oncology, 2011-10, Vol.18 (10), p.2748-2756

2011

Volltextzugriff (PDF)

Histoepigenetic analysis of HPV- and tobacco-associated head and neck cancer identifies both subtype-specific and common therapeutic targets despite divergent microenvironments

Oncogene, 2019-05, Vol.38 (19), p.3551-3568

2019

Volltextzugriff (PDF)

Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release

The Journal of immunology (1950), 2012-06, Vol.188 (11), p.5365-5376

2012

Volltextzugriff (PDF)

Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy

Frontiers in immunology, 2022-01, Vol.13, p.840923-840923

2022

Volltextzugriff (PDF)

Inducible Nitric Oxide Synthase Drives mTOR Pathway Activation and Proliferation of Human Melanoma by Reversible Nitrosylation of TSC2

Cancer research (Chicago, Ill.), 2014-02, Vol.74 (4), p.1067-1078

2014

Volltextzugriff (PDF)

Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer

Cancer research (Chicago, Ill.), 2014-12, Vol.74 (24), p.7205-7216

2014

Volltextzugriff (PDF)

Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma

BMC cancer, 2020-09, Vol.20 (1), p.912-12, Article 912

2020

Volltextzugriff (PDF)

Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects

Journal for immunotherapy of cancer, 2021-07, Vol.9 (7), p.e002773

2021

Volltextzugriff (PDF)

Transoral robotic resection and reconstruction for head and neck cancer

The Laryngoscope, 2011-08, Vol.121 (8), p.1668-1674

2011

Volltextzugriff (PDF)

Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma

The American journal of pathology, 2018-01, Vol.188 (1), p.72-83

2018

Volltextzugriff (PDF)

TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy

Oncoimmunology, 2018-10, Vol.7 (10), p.e1490853-e1490853

2018

Volltextzugriff (PDF)

Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition

Journal for immunotherapy of cancer, 2019-08, Vol.7 (1), p.216-21, Article 216

2019

Volltextzugriff (PDF)

Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer

Cancer causes & control, 2011-05, Vol.22 (5), p.671-679

2011

Volltextzugriff (PDF)

Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer

Immunologic research, 2012-12, Vol.54 (1-3), p.266-274

2012

Volltextzugriff (PDF)

Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

Journal for immunotherapy of cancer, 2019-01, Vol.7 (1), p.10-19, Article 10

2019

Volltextzugriff (PDF)

Survival outcomes in advanced laryngeal cancer

JAMA otolaryngology-- head & neck surgery, 2014-09, Vol.140 (9), p.855

2014

Volltextzugriff (PDF)

Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response

Journal for immunotherapy of cancer, 2022-08, Vol.10 (8), p.e004752

2022

Volltextzugriff (PDF)

Hypermethylation of nc886 in HPV-positive oropharyngeal cancer and its clinical implications: An epigenome-wide association study

Molecular therapy. Nucleic acids, 2022-12, Vol.30, p.596-605

2022

Volltextzugriff (PDF)

Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival

Thyroid (New York, N.Y.), 2010-02, Vol.20 (2), p.153

2010

Volltextzugriff (PDF)

1 – 25 von 212

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(190)

Publikationsform

Sprache

Englisch
(211)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The increasing incidence of thyroid cancer: the influence of access to care

STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

Second Primary Cancers After an Index Head and Neck Cancer: Subsite-Specific Trends in the Era of Human Papillomavirus–Associated Oropharyngeal Cancer

Molecular Pathways: Inflammation-Associated Nitric-Oxide Production as a Cancer-Supporting Redox Mechanism and a Potential Therapeutic Target

Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization

Predictors of Survival in Mucosal Melanoma of the Head and Neck

Histoepigenetic analysis of HPV- and tobacco-associated head and neck cancer identifies both subtype-specific and common therapeutic targets despite divergent microenvironments

Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release

Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy

Inducible Nitric Oxide Synthase Drives mTOR Pathway Activation and Proliferation of Human Melanoma by Reversible Nitrosylation of TSC2

Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer

Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma

Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects

Transoral robotic resection and reconstruction for head and neck cancer

Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma

TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy

Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition

Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer

Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer

Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

Survival outcomes in advanced laryngeal cancer

Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response

Hypermethylation of nc886 in HPV-positive oropharyngeal cancer and its clinical implications: An epigenome-wide association study

Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival

Suchergebnisse filtern